SCHEMBL247742

SCHEMBL247742

C[C@H](NC(=O)O)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.63
▸ MEN1 O00255 1/20 0.61
▸ KMT2A Q03164 1/20 0.61
▸ ALDH1A1 P00352 5/20 0.59
▸ HPGD P15428 3/20 0.59
▸ KDM4E B2RXH2 2/20 0.59
▸ LMNA P02545 2/20 0.59
▸ POLB P06746 2/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ CTDSP1 Q9GZU7 1/20 0.58
▸ RECQL P46063 1/20 0.58
▸ MAPT P10636 1/20 0.58
▸ NPC1 O15118 1/20 0.58
▸ MMP9 P14780 1/20 0.56
▸ MMP8 P22894 1/20 0.56
▸ HDAC3 O15379 1/20 0.56
▸ HDAC4 P56524 1/20 0.56
▸ HDAC1 Q13547 1/20 0.56
▸ CASR P41180 1/20 0.56
▸ HDAC6 Q9UBN7 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2672977 1.00 HSD17B10 (0.63) HSD17B10MEN1KMT2AALDH1A1HPGD
SCHEMBL249524 1.00 HSD17B10 (0.63) HSD17B10MEN1KMT2AALDH1A1HPGD
Hydrochloric Acid SCHEMBL4459970 0.98 HSD17B10 (0.61) HSD17B10MEN1KMT2AALDH1A1HPGD
SCHEMBL9718520 0.98 HSD17B10 (0.61) HSD17B10MEN1KMT2AALDH1A1HPGD
Chloromethane SCHEMBL29855624 0.96 HSD17B10 (0.59) HSD17B10MEN1KMT2AALDH1A1HPGD
SCHEMBL28210163 0.94 HSD17B10 (0.58) HSD17B10MEN1KMT2AALDH1A1HPGD
SCHEMBL28305666 0.92 HSD17B10 (0.56) HSD17B10MEN1KMT2AALDH1A1HPGD
Alcohol SCHEMBL28032632 0.92 MEN1 (0.64) HSD17B10MEN1KMT2AALDH1A1HPGD
SCHEMBL17571990 0.88 ALDH1A1 (0.61) HSD17B10MEN1KMT2AALDH1A1HPGD
SCHEMBL28306863 0.87 HSD17B10 (0.51) HSD17B10MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116283557-B Resolution method of S-type and R-type flurbiprofen 江苏汉邦科技股份有限公司 2025-02-25 — — CN claimed
EP-4069691-B1 SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMA (US) 2024-09-18 — — EP claimed
CN-116283557-A Resolution method of S-type and R-type flurbiprofen 江苏汉邦科技股份有限公司 2023-06-23 — — CN claimed
EP-3364940-B1 METHOD OF CHROMATOGRAPHIC SEPARATION PROCTER & GAMBLE (US) 2019-08-07 — — EP claimed
US-10035759-B2 Method of chromatographic separation THE PROCTER & GAMBLE COMPANY (US) 2018-07-31 — — US claimed
US-20170036994-A1 METHOD OF CHROMATOGRAPHIC SEPARATION THE PROCTER & GAMBLE COMPANY 2017-02-09 — — US claimed
US-8569499-B2 Process for making trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine H. LUNDBECK A/S (DK) 2013-10-29 — — US claimed
EP-2352721-B1 NOVEL PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES UCB PHARMA GMBH (DE) 2013-03-27 — — EP claimed
EP-1968916-B1 Process for the separation of optical isomers of the corey lactone CHINOIN GYOGYSZER ES VEGYESZET (HU) 2012-07-11 — — EP claimed
EP-1828198-B1 METHOD FOR SEPARATING OF OPTICALLY PURE THIOPHENE COMPOUNDS USING SIMULATED MOVING BED CHROMATOGRAPHY SK HOLDINGS CO LTD (KR) 2011-02-09 — — EP claimed
US-7166587-B2 Carbamic acid alkyl ester derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-23 — — US claimed
US-20060063746-A1 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators MERCK SHARP & DOHME CORP. 2006-03-23 — — US claimed
EP-1587818-A2 17-CARBAMOYLOXY CORTISOL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2005-10-26 — — EP claimed
US-20050075327-A1 Carbamic acid alkyl ester derivatives HOFFMAN-LA ROCHE INC. 2005-04-07 — — US claimed
WO-2004066920-A2 17-CARBAMOYLOXY CORTISOL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS MERCK & CO. INC. (US) 2004-08-12 — — WO claimed
EP-0865430-B1 3-(4-SUBST.-PIPERIDINYL-1)-1-(3,4-DICHLOROPHENYL)PROPYL CARBAMATES AND UREAS AND DERIVATIVES AS NOVEL NEUROKININ ANTAGONISTS ASTRAZENECA AB (SE) 2004-03-03 — — EP claimed
US-RE37303-E1 Imidazole compounds and their therapeutic applications INSTITUT NATIONAL DEL LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2001-07-31 — — US claimed
EP-0865430-A1 3-(4-SUBST.-PIPERIDINYL-1)-1-(3,4-DICHLOROPHENYL)PROPYL CARBAMATES AND UREAS AND DERIVATIVES AS NOVEL NEUROKININ ANTAGONISTS AstraZeneca AB (SE) 1998-09-23 — — EP claimed
US-5708171-A HISTAMINE H3-RECEPTOR ANTAGONIST INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1998-01-13 — — US claimed
WO-1997019060-A1 3-(4-SUBST.-PIPERIDINYL-1)-1-(3,4-DICHLOROPHENYL)PROPYL CARBAMATES AND UREAS AND DERIVATIVES AS NOVEL NEUROKININ ANTAGONISTS ZENECA LIMITED (GB) 1997-05-29 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075327-A1 Carbamic acid alkyl ester derivatives BCHE, CHRM1, ADCY7 HSD17B10 1009/4885MEN1 1340/4885KMT2A 2212/4885
US-20170036994-A1 METHOD OF CHROMATOGRAPHIC SEPARATION AVPR2, SHBG, AVPR1B HSD17B10 336/4885MEN1 1199/4885KMT2A 4552/4885
US-20060063746-A1 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators NR3C1, NR3C2, MC2R HSD17B10 153/4885MEN1 1772/4885KMT2A 2954/4885
US-10035759-B2 Method of chromatographic separation AVPR2, SHBG, AVPR1B HSD17B10 336/4885MEN1 1199/4885KMT2A 4552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback